MCS trades 3.6% above Wall Street's consensus target of $23.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MCS achieves its forward estimates and maintains a stable P/E multiple of 46.1x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, The Marcus Corporation (MCS) has a Wall Street consensus price target of $23.00, based on estimates from 8 covering analysts. With the stock currently trading at $23.85, this represents a potential downside of -3.6%. The company has a market capitalization of $743M.
Analyst price targets range from a low of $23.00 to a high of $23.00, representing a 0% spread in expectations. The median target of $23.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, MCS trades at a trailing P/E of 58.2x and forward P/E of 46.1x. Analysts expect EPS to grow +12.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $13.77, with bear and bull scenarios of $8.68 and $18.14 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CNKCinemark Holdings, Inc. | $3.9B | $33.76 | $32.20 | -4.6% | Buy | 15.8x | 31 |
AMCAMC Entertainment Holdings, Inc. | $1.7B | $2.83 | $1.50 | -47.0% | Hold | — | 28 |
IMAXIMAX Corporation | $2.4B | $44.33 | $53.00 | +19.6% | Buy | 26.2x | 25 |
HGVHilton Grand Vacations Inc. | $4.3B | $52.73 | $52.00 | -1.4% | Hold | 9.6x | 16 |
SHOSunstone Hotel Investors, Inc. | $2.2B | $11.91 | $10.50 | -11.8% | Hold | 86.7x | 28 |
RHPRyman Hospitality Properties, Inc. | $7.9B | $125.15 | $123.43 | -1.4% | Buy | 30.6x | 19 |
INNSummit Hotel Properties, Inc. | $721M | $6.63 | $6.50 | -2.0% | Buy | — | 14 |
APLEApple Hospitality REIT, Inc. | $3.9B | $16.59 | $16.00 | -3.6% | Buy | 24.2x | 17 |
DISThe Walt Disney Company | $180.4B | $103.89 | $139.20 | +34.0% | Buy | 15.2x | 63 |
WBDWarner Bros. Discovery, Inc. | $65.7B | $26.20 | $30.80 | +17.6% | Hold | — | 32 |
Quick answers to the most common questions about buying MCS stock.
Wall Street's consensus price target for MCS is $23, -3.6% from its current price of $23.85. The below-market target from 8 analysts suggests limited near-term appreciation.
MCS has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $23 implies -3.6% downside from current levels.
At a forward P/E of 46.087x, MCS trades at a premium valuation. The consensus price target of $23 (-3.6% downside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $23 for MCS, while the most conservative target is $23. The consensus of $23 represents the median expectation. Our quantitative valuation model projects a bull case target of $18 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MCS is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MCS stock forecast based on 8 Wall Street analysts shows a consensus price target of $23, with estimates ranging from $23 (bear case) to $23 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $9/$18.
Our quantitative valuation model calculates MCS's fair value at $14 (base case), with a bear case of $9 and bull case of $18. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
MCS trades at a forward P/E ratio of 46.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 58.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on MCS, with 0 Sell ratings and a price target of $23 (-3.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MCS analyst price targets range from $23 to $23, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $23 consensus represents the middle ground. Our model's $9-$18 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.